Joseph H. Antin is Professor of Medicine at Harvard Medical School and Chief of the Stem Cell Transplant Program at the Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Deborah Yolin Raley is the Director of the Physician Assistant Program and a practising Physician Assistant in the Hematopoietic Stem Cell Transplant Program at the Dana-Farber Cancer Institute, Boston, MA, USA.

Select Guide Rating

• Acknowledgements; 1. Rationale for transplantation; 2. Types of transplantation; 3. HLA matching in allogeneic transplantation; 4. Stem cell source; 5. Pre-transplant evaluation and counselling of patient and donor; 6. Conditioning regimens; 7. Stem cell infusion; 8. ABO compatibility; 9. Engraftment; 10. Preventative care; 11. Transplant-related complications; 12. Overview of acute and chronic graft-versus-host disease; 13. Acute graft-versus-host disease and staging; 14. Graft-versus-host prophylactic regimens; 15. Treatment guidelines for acute graft-versus-host disease; 16. Chronic graft-versus-host disease; 17. Engraftment syndrome; 18. Infectious disease; 19. Graft rejection and failure; 20. Gastrointestinal complications; 21. Oral health in stem cell transplantation; 22. Pulmonary complications; 23. Veno-occlusive disease; 24. Special transfusion-related situations; 25. Cardiovascular complications; 26. Neurologic complications; 27. Cystitis; 28. Donor lymphocyte infusion; 29. Transplantation: regulation and accreditation; Index.

Joseph H. Antin is Professor of Medicine at Harvard Medical School and Chief of the Stem Cell Transplant Program at the Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Deborah Yolin Raley is the Director of the Physician Assistant Program and a practising Physician Assistant in the Hematopoietic Stem Cell Transplant Program at the Dana-Farber Cancer Institute, Boston, MA, USA.

Select Guide Rating

• Acknowledgements; 1. Rationale for transplantation; 2. Types of transplantation; 3. HLA matching in allogeneic transplantation; 4. Stem cell source; 5. Pre-transplant evaluation and counselling of patient and donor; 6. Conditioning regimens; 7. Stem cell infusion; 8. ABO compatibility; 9. Engraftment; 10. Preventative care; 11. Transplant-related complications; 12. Overview of acute and chronic graft-versus-host disease; 13. Acute graft-versus-host disease and staging; 14. Graft-versus-host prophylactic regimens; 15. Treatment guidelines for acute graft-versus-host disease; 16. Chronic graft-versus-host disease; 17. Engraftment syndrome; 18. Infectious disease; 19. Graft rejection and failure; 20. Gastrointestinal complications; 21. Oral health in stem cell transplantation; 22. Pulmonary complications; 23. Veno-occlusive disease; 24. Special transfusion-related situations; 25. Cardiovascular complications; 26. Neurologic complications; 27. Cystitis; 28. Donor lymphocyte infusion; 29. Transplantation: regulation and accreditation; Index.

Joseph H. Antin is Professor of Medicine at Harvard Medical School and Chief of the Stem Cell Transplant Program at the Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. Deborah Yolin Raley is the Director of the Physician Assistant Program and a practising Physician Assistant in the Hematopoietic Stem Cell Transplant Program at the Dana-Farber Cancer Institute, Boston, MA, USA.

Select Guide Rating

• Acknowledgements; 1. Rationale for transplantation; 2. Types of transplantation; 3. HLA matching in allogeneic transplantation; 4. Stem cell source; 5. Pre-transplant evaluation and counselling of patient and donor; 6. Conditioning regimens; 7. Stem cell infusion; 8. ABO compatibility; 9. Engraftment; 10. Preventative care; 11. Transplant-related complications; 12. Overview of acute and chronic graft-versus-host disease; 13. Acute graft-versus-host disease and staging; 14. Graft-versus-host prophylactic regimens; 15. Treatment guidelines for acute graft-versus-host disease; 16. Chronic graft-versus-host disease; 17. Engraftment syndrome; 18. Infectious disease; 19. Graft rejection and failure; 20. Gastrointestinal complications; 21. Oral health in stem cell transplantation; 22. Pulmonary complications; 23. Veno-occlusive disease; 24. Special transfusion-related situations; 25. Cardiovascular complications; 26. Neurologic complications; 27. Cystitis; 28. Donor lymphocyte infusion; 29. Transplantation: regulation and accreditation; Index.